BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 2877731)

  • 1. Differential expression of cell surface antigens and glial fibrillary acidic protein in human astrocytoma subsets.
    Rettig WJ; Chesa PG; Beresford HR; Feickert HJ; Jennings MT; Cohen J; Oettgen HF; Old LJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6406-12. PubMed ID: 2877731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical analysis of the A4 and AO10 (gp110) cell-surface antigens of human astrocytoma.
    Garin-Chesa P; Beresford HR; Walker S; Rettig WJ
    Am J Pathol; 1990 Apr; 136(4):797-807. PubMed ID: 2183624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
    Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
    Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial fibrillary acidic protein expression in pleomorphic adenoma, chordoma, and astrocytoma. A comparison of three antibodies.
    Wittchow R; Landas SK
    Arch Pathol Lab Med; 1991 Oct; 115(10):1030-3. PubMed ID: 1654872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface antigens of human astrocytoma defined by mouse monoclonal antibodies: identification of astrocytoma subsets.
    Cairncross JG; Mattes MJ; Beresford HR; Albino AP; Houghton AN; Lloyd KO; Old LJ
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5641-5. PubMed ID: 6182568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
    Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
    Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
    Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
    Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell surface antigen expressed by astrocytes and their precursors.
    Szigeti V; Miller RH
    Glia; 1993 May; 8(1):20-32. PubMed ID: 7685323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfection of human astrocytoma cells with glial fibrillary acidic protein complementary DNA: analysis of expression, proliferation, and tumorigenicity.
    Rutka JT; Smith SL
    Cancer Res; 1993 Aug; 53(15):3624-31. PubMed ID: 8339269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schwannian cell differentiation of human neuroblastoma cell lines in vitro induced by bromodeoxyuridine.
    Sugimoto T; Kato T; Sawada T; Horii Y; Kemshead JT; Hino T; Morioka H; Hosoi H
    Cancer Res; 1988 May; 48(9):2531-7. PubMed ID: 2833349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antisense glial fibrillary acidic protein complementary DNA on the growth, invasion, and adhesion of human astrocytoma cells.
    Rutka JT; Hubbard SL; Fukuyama K; Matsuzawa K; Dirks PB; Becker LE
    Cancer Res; 1994 Jun; 54(12):3267-72. PubMed ID: 8205549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of four intermediate filament subclasses in childhood glial neoplasms.
    Bodey B; Cosgrove M; Gonzalez-Gomez I; Siegel SE; Martin SE; Gilles FH
    Mod Pathol; 1991 Nov; 4(6):742-9. PubMed ID: 1724088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of glial filament-cytoskeletal interactions in human astrocytomas: an immuno-ultrastructural analysis.
    Rutka JT; Ackerley C; Hubbard SL; Tilup A; Dirks PB; Jung S; Ivanchuk S; Kurimoto M; Tsugu A; Becker LE
    Eur J Cell Biol; 1998 Aug; 76(4):279-87. PubMed ID: 9765058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of a cell surface antigen found on rat peripheral nervous system neurons and multiple glia: astrocytes, oligodendrocytes, and Schwann cells.
    Akeson R; Warren SL
    J Neurosci Res; 1984; 12(1):41-57. PubMed ID: 6384527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducible expression of glial fibrillary acidic protein in HT-1080 human fibrosarcoma cells.
    Murakami M; Fukuyama K; Hubbard S; Matsuzawa K; Dirks PB; Rutka JT
    Cell Growth Differ; 1996 Dec; 7(12):1697-703. PubMed ID: 8959338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual lineage of astrocytomas.
    Bishop M; de la Monte SM
    Am J Pathol; 1989 Sep; 135(3):517-27. PubMed ID: 2551172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell surface antigens of human bladder tumors: definition of tumor subsets by monoclonal antibodies and correlation with growth characteristics.
    Fradet Y; Cordon-Cardo C; Whitmore WF; Melamed MR; Old LJ
    Cancer Res; 1986 Oct; 46(10):5183-8. PubMed ID: 3756873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
    Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
    Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A monoclonal antibody which discriminates between sub-types of astrocytoma.
    Sarawar SR; Bonshek RE; Marsden HB; Yates PO; Kumar S
    Anticancer Res; 1991; 11(4):1429-32. PubMed ID: 1746899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.